Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Riederer

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 11, 2017
The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitroJasmin Bartl, Ferruccio Palazzesi, Michele Parrinello, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 12, 2010
Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's diseaseEdna Grünblatt, Sonja Zehetmayer, Christian P Jacob, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 16, 2010
Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophreniaTanja Maria Michel, Abigail Jane Sheldrick, Sybille Camara, et al.
Neuro-Degenerative Diseases|March 7, 2008
Early detection of Parkinson's disease: unmet needsManfred Gerlach, Albrecht Hendrich, Roland Hueber, et al.
Cells|September 27, 2024
Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary DataSabrina Strobel, Jeswinder Sian-Hulsmann, Dennis Tappe, et al.
Microorganisms|August 27, 2021
No Metagenomic Evidence of Causative Viral Pathogens in Postencephalitic Parkinsonism Following Encephalitis LethargicaDániel Cadar, Kurt A Jellinger, Peter Riederer, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled TrialsStefan Strilciuc, László Vécsei, Dana Boering, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 16, 2012
Alzheimer's disease and type 2 diabetes: two diseases, one common link?Jasmin Bartl, Camelia-Maria Monoranu, Anne-Kristin Wagner, et al.
International Clinical Psychopharmacology|December 31, 2013
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditionsStefan Unterecker, Andreas Reif, Susanne Hempel, et al.
CNS Drugs|July 23, 2003
Neuroprotective strategies in Parkinson's disease : an update on progressSilvia Mandel, Edna Grünblatt, Peter Riederer, et al.
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 11, 2017
The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitroJasmin Bartl, Ferruccio Palazzesi, Michele Parrinello, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 12, 2010
Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's diseaseEdna Grünblatt, Sonja Zehetmayer, Christian P Jacob, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 16, 2010
Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophreniaTanja Maria Michel, Abigail Jane Sheldrick, Sybille Camara, et al.
Neuro-Degenerative Diseases|March 7, 2008
Early detection of Parkinson's disease: unmet needsManfred Gerlach, Albrecht Hendrich, Roland Hueber, et al.
Cells|September 27, 2024
Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary DataSabrina Strobel, Jeswinder Sian-Hulsmann, Dennis Tappe, et al.
Microorganisms|August 27, 2021
No Metagenomic Evidence of Causative Viral Pathogens in Postencephalitic Parkinsonism Following Encephalitis LethargicaDániel Cadar, Kurt A Jellinger, Peter Riederer, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled TrialsStefan Strilciuc, László Vécsei, Dana Boering, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 16, 2012
Alzheimer's disease and type 2 diabetes: two diseases, one common link?Jasmin Bartl, Camelia-Maria Monoranu, Anne-Kristin Wagner, et al.
International Clinical Psychopharmacology|December 31, 2013
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditionsStefan Unterecker, Andreas Reif, Susanne Hempel, et al.
CNS Drugs|July 23, 2003
Neuroprotective strategies in Parkinson's disease : an update on progressSilvia Mandel, Edna Grünblatt, Peter Riederer, et al.
Pageof 25